ReviewGels (Basel, Switzerland)2026
Injectable Conductive Hydrogels as Multifunctional Bioactive Soft Interfaces for Skeletal Muscle Regeneration.
Review in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The skeletal muscle is an essential organ in exercise and energy metabolism and it significantly contributes to maintaining body posture, facilitating movement, and supporting overall health. The skeletal muscle has an intrinsic capacity for self-repair and functional restoration following minor injury. However, this reparative ability is limited, and in cases of volumetric muscle loss (VML) caused by traumatic injury or tumor resection, substantial muscle loss and functional impairments may occur. Injectable conductive hydrogels (ICHs) have received increasing attention in the repair and regeneration of VML due to their controlled conductivity and minimally invasive application. In ICHs, conductive mediums are introduced into a hydrogel to improve the electrical integration between hydrogel and host tissue, promoting skeletal muscle repair. Furthermore, shear-thinning ICHs that undergo in situ gelation can reduce the injury size and inflammation, thus approaching the clinical transformation target of conductive biomaterials. Notably, ICHs can also serve as carriers of bioactive molecules or cells to improve the cellular microenvironment in the injured region and induce skeletal muscle regeneration. This review focuses on exploring different conductive mediums integrated into ICHs, including their formation principles, key performance metrics, immunoregulatory activity, and potential applications in skeletal muscle regeneration. Additionally, this review emphasizes the future development and optimization of ICHs to enhance skeletal muscle repair and regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.